Literature DB >> 22522444

Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts.

Aaron R Folsom1, Hiroshi Yatsuya, Thomas H Mosley, Bruce M Psaty, W T Longstreth.   

Abstract

OBJECTIVE: To determine whether the burden of leukoaraiosis and the number of brain infarcts, defined by magnetic resonance imaging (MRI), are prospectively and independently associated with intraparenchymal hemorrhage (IPH) incidence in a pooled population-based study.
METHODS: Among 4,872 participants initially free of clinical stroke in the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study, we assessed white matter grade (range, 0-9), reflecting increasing leukoaraiosis, and brain infarcts using MRI. Over a median of 13 years of follow-up, 71 incident, spontaneous IPH events occurred.
RESULTS: After adjustment for other IPH risk factors, the hazard ratios (95% confidence intervals) across white matter grades 0 to 1, 2, 3, and 4 to 9 were 1.00, 1.68 (0.86-3.30), 3.52 (1.80-6.89), and 3.96 (1.90-8.27), respectively (p for trend <0.0001). These hazard ratios were weakened only modestly (p for trend = 0.0003) with adjustment for MRI-defined brain infarcts. The IPH hazard ratios for 0, 1, 2, or ≥3 MRI-defined brain infarcts were 1.00, 1.97 (1.10-3.54), 2.00 (0.83-4.78), and 3.12 (1.31-7.43) (p for trend = 0.002), but these were substantially attenuated when adjusted for white matter grade (p for trend = 0.049).
INTERPRETATION: Greater MRI-defined burden of leukoaraiosis is a risk factor for spontaneous IPH. Spontaneous IPH should be added to the growing list of potential poor outcomes in people with leukoaraiosis.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Year:  2012        PMID: 22522444      PMCID: PMC3377969          DOI: 10.1002/ana.22690

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  28 in total

1.  Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group.

Authors: 
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

3.  Leuko-araiosis: an ancient term for a new problem.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

4.  The National Survey of Stroke. Study design and methodology.

Authors:  M Robins; F D Weinfeld
Journal:  Stroke       Date:  1981 Mar-Apr       Impact factor: 7.914

5.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study.

Authors:  W T Longstreth; C Bernick; A Fitzpatrick; M Cushman; L Knepper; J Lima; C D Furberg
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

6.  Assessment of cerebrovascular disease in the Cardiovascular Health Study.

Authors:  T R Price; B Psaty; D O'Leary; G Burke; J Gardin
Journal:  Ann Epidemiol       Date:  1993-09       Impact factor: 3.797

7.  Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.

Authors:  E E Smith; J Rosand; K A Knudsen; E M Hylek; S M Greenberg
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

8.  Cerebral white matter lesions, retinopathy, and incident clinical stroke.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Leukoaraiosis and intracerebral hematoma.

Authors:  K Selekler; C Erzen
Journal:  Stroke       Date:  1989-08       Impact factor: 7.914

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  20 in total

1.  Leukoaraiosis and NIHSS score help to differentiate subtypes of intracranial branch atheromatous disease in Southern Han Chinese patients with stroke.

Authors:  Xuejiao Men; Aimin Wu; Bingjun Zhang; Haiyan Li; Lei Zhang; Suqin Chen; Yinyao Lin; Zhengqi Lu
Journal:  Neurol Sci       Date:  2013-02-22       Impact factor: 3.307

2.  Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease.

Authors:  Curtis R French; Sudha Seshadri; Anita L Destefano; Myriam Fornage; Corey R Arnold; Philip J Gage; Jonathan M Skarie; William B Dobyns; Kathleen J Millen; Ting Liu; William Dietz; Tsutomu Kume; Marten Hofker; Derek J Emery; Sarah J Childs; Andrew J Waskiewicz; Ordan J Lehmann
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

3.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 4.  Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.

Authors:  Mark R Etherton; Ona Wu; Natalia S Rost
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

5.  Small Brain Lesions and Incident Stroke and Mortality: A Cohort Study.

Authors:  B Gwen Windham; Bradley Deere; Michael E Griswold; Wanmei Wang; Daniel C Bezerra; Dean Shibata; Kenneth Butler; David Knopman; Rebecca F Gottesman; Gerardo Heiss; Thomas H Mosley
Journal:  Ann Intern Med       Date:  2015-07-07       Impact factor: 25.391

6.  Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.

Authors:  Cathy R Zhang; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Alison M Ayres; Karen L Furie; Jonathan Rosand; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-06       Impact factor: 2.136

Review 7.  Use of rivaroxaban in patients with stroke.

Authors:  Danilo Toni; Antonio Carolei; Valeria Caso; Domenico Consoli; Massimo Del Sette; Domenico Inzitari; Maurizio Melis; Giuseppe Micieli; Leandro Provinciali; Stefano Ricci; Paola Santalucia; Vito Toso
Journal:  Neurol Sci       Date:  2017-02-25       Impact factor: 3.307

8.  Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Authors:  Hyung-Min Kwon; Michael J Lynn; Tanya N Turan; Colin P Derdeyn; David Fiorella; Bethany F Lane; Jean Montgomery; L Scott Janis; Zoran Rumboldt; Marc I Chimowitz
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

9.  White matter disease as a biomarker for long-term cerebrovascular disease and dementia.

Authors:  Aurauma Chutinet; Natalia S Rost
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

Review 10.  [Troponin elevation in ischemic stroke patients].

Authors:  C H Nolte; J F Scheitz; M Endres
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-12       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.